TRAK2, a novel regulator of ABCA1 expression, cholesterol efflux and HDL biogenesis
© The Author 2017. Aims The recent failures of HDL-raising therapies have underscored our incomplete understanding of HDL biology. Therefore there is an urgent need to comprehensively investigate HDL metabolism to enable the development of effective HDL-centric therapies. To identify novel regulator...
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Oxford University Press
2017
|
| Online Access: | http://hdl.handle.net/20.500.11937/63381 |